NEW YORK (GenomeWeb) – The National Institutes of Health will pump up to $24 million into research programs that will analyze genomic data from thousands of Alzheimer's patients in search of variants that may be involved in or affect the disease.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: factors influencing retrotransposon integration sites, and more.
A bioethicist argues for the responsible use of germline gene editing.
Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.
Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.
This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.